NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $706,705 | +0.9% | 6,938 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $700,114 | +109635.7% | 6,938 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $638 | +1.4% | 6,938 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $629 | -99.9% | 6,938 | -10.3% | 0.02% | -5.6% |
| Q3 2022 | $588,000 | -29.7% | 7,738 | -21.7% | 0.02% | -25.0% |
| Q2 2022 | $836,000 | +0.1% | 9,888 | +3.9% | 0.02% | +20.0% |
| Q1 2022 | $835,000 | +0.4% | 9,516 | 0.0% | 0.02% | +5.3% |
| Q4 2021 | $832,000 | -28.9% | 9,516 | -33.5% | 0.02% | -34.5% |
| Q3 2021 | $1,170,000 | -12.5% | 14,308 | -2.4% | 0.03% | -12.1% |
| Q2 2021 | $1,337,000 | +3.2% | 14,658 | -3.3% | 0.03% | -5.7% |
| Q1 2021 | $1,296,000 | -21.4% | 15,158 | -13.1% | 0.04% | -25.5% |
| Q4 2020 | $1,648,000 | +4.8% | 17,447 | -3.5% | 0.05% | -7.8% |
| Q3 2020 | $1,572,000 | +75.3% | 18,072 | +76.0% | 0.05% | +54.5% |
| Q2 2020 | $897,000 | -14.2% | 10,270 | -18.9% | 0.03% | -29.8% |
| Q1 2020 | $1,045,000 | -9.4% | 12,670 | +4.0% | 0.05% | +14.6% |
| Q4 2019 | $1,154,000 | -13.1% | 12,182 | -20.3% | 0.04% | -19.6% |
| Q3 2019 | $1,328,000 | -3.0% | 15,282 | +1.9% | 0.05% | -7.3% |
| Q2 2019 | $1,369,000 | -30.6% | 14,995 | -26.9% | 0.06% | -36.0% |
| Q1 2019 | $1,973,000 | +6.0% | 20,520 | -5.4% | 0.09% | -7.5% |
| Q4 2018 | $1,862,000 | -3.5% | 21,695 | -3.1% | 0.09% | +9.4% |
| Q3 2018 | $1,930,000 | -24.1% | 22,395 | -33.4% | 0.08% | -25.4% |
| Q2 2018 | $2,542,000 | -93.2% | 33,645 | -92.7% | 0.11% | -93.7% |
| Q1 2018 | $37,243,000 | -0.6% | 460,641 | +3.2% | 1.82% | -10.9% |
| Q4 2017 | $37,460,000 | -1.8% | 446,164 | +0.5% | 2.04% | -7.9% |
| Q3 2017 | $38,128,000 | +2.7% | 444,123 | -0.1% | 2.21% | -1.6% |
| Q2 2017 | $37,120,000 | +12.3% | 444,714 | -0.1% | 2.25% | +9.1% |
| Q1 2017 | $33,059,000 | +8.3% | 445,114 | +6.2% | 2.06% | +0.1% |
| Q4 2016 | $30,516,000 | -4.5% | 418,949 | +3.5% | 2.06% | -6.8% |
| Q3 2016 | $31,962,000 | -2.9% | 404,784 | +1.5% | 2.21% | -4.8% |
| Q2 2016 | $32,917,000 | +15.6% | 398,940 | +1.5% | 2.32% | +13.1% |
| Q1 2016 | $28,466,000 | -9.4% | 392,964 | +7.6% | 2.05% | -11.8% |
| Q4 2015 | $31,414,000 | -2.0% | 365,108 | +4.7% | 2.33% | -7.8% |
| Q3 2015 | $32,050,000 | -1.6% | 348,668 | +5.5% | 2.53% | -0.2% |
| Q2 2015 | $32,577,000 | 0.0% | 330,359 | 0.0% | 2.53% | 0.0% |
| Q1 2015 | $32,577,000 | +19.0% | 330,359 | +11.8% | 2.53% | +3.7% |
| Q4 2014 | $27,370,000 | -0.6% | 295,380 | +1.0% | 2.44% | -3.9% |
| Q3 2014 | $27,525,000 | +4.7% | 292,420 | +0.7% | 2.54% | +4.9% |
| Q2 2014 | $26,278,000 | +7.9% | 290,265 | +1.3% | 2.42% | +0.6% |
| Q1 2014 | $24,360,000 | +9.9% | 286,520 | +3.9% | 2.40% | +4.5% |
| Q4 2013 | $22,163,000 | +6.7% | 275,725 | +1.8% | 2.30% | -4.5% |
| Q3 2013 | $20,769,000 | +11.3% | 270,745 | +2.6% | 2.41% | +6.7% |
| Q2 2013 | $18,658,000 | – | 263,860 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |